Clinical trial Recruiting at 1 site Interventional Ages 75 and up

Improving collaboration in osteoporosis treatment after hip fractures

Official title: Collaboration to Improve Bone Health

Run by University Hospital, Akershus · NCT05904353 · Data updated 2026-11-12

This study is testing if better teamwork between doctors can help older patients who have had a hip fracture get the right osteoporosis treatment to prevent more fractures.

Quick facts

Study typeInterventional
Ages75 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity Hospital, Akershus
Academic / other
Locations1 site (Lørenskog, Akershus)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 2025
Study endsDecember 2026
Registry record updatedFebruary 5, 2024
Trial IDNCT05904353 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 75 years or older who have experienced a hip fracture.

Probably not a fit

Patients who refuse treatment, have other osteoporosis treatments indicated, or have dementia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the cooperation between primary and secondary healthcare providers in treating osteoporosis following a hip fracture in patients aged 75 and older. Participants will receive an infusion of zoledronic acid, along with vitamin D and calcium supplements, to prevent further fractures. General practitioners will be involved in the follow-up care, administering annual infusions of zoledronic acid for three years after the initial treatment. The goal is to ensure that patients continue receiving necessary treatments after hospital discharge.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of new fractures in elderly patients by ensuring consistent osteoporosis treatment.

How similar studies have gone: While similar collaborative approaches have been explored, this specific intervention focusing on post-hip fracture osteoporosis treatment is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients 75 years or older with a hip fracture

Exclusion Criteria:

* Refuse treatment
* Another treatment of osteoporosis is indicated
* Guest patient, do not live in the admission area
* Dementia

Where it's running

  • Orthopedic Department, Akershus University Hospital
    Lørenskog, Akershus, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.